“It’s time to reorient the mindset around Pharmaceutical Benefits Scheme reimbursement. Australians with a clear medical need should not miss out on access to an innovative medicine with proven clinical benefit because the patient pool is considered too large to allow for Government funding,” said Eli Lilly general manager Tori Brown. …
'A procurement mindset must not impede equitable access to medicines that offer significant benefits'
November 14, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The industry walked out on Britain, and what it cost to win them back
October 22, 2026 - - Latest News -
BioNTech opens mRNA plant, putting Melbourne's north on the biotech map
October 22, 2026 - - Latest News -
An architect of the first industry–Commonwealth medicines pact to lead CSL
October 21, 2026 - - Latest News -
Quarterly update shows Telix holds course for a US$1 billion milestone year
October 21, 2026 - - Latest News -
Chemist Warehouse keeps growing as Sigma sets its sights on oral GLP-1s
October 21, 2026 - - Latest News -
America's ever rising GLP-1 curve and how Australia is following
October 21, 2026 - - Latest News -
Patient groups across Asia-Pacific push for a say on medicine prices
October 21, 2026 - - Latest News